Codes | Health states | Description | Rank | Perfect health lasting 12 months (%) | Oropharyngeal cancer duration | |||||
---|---|---|---|---|---|---|---|---|---|---|
12 months | Lifetime |  | ||||||||
Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | ICC | |||
S1 | Screened; cytology normal | OPSCC screening test cytology negative (Roger) | 1 (1) | 85.1 (16.7) | 90.0 (20.0) | 0.91 (0.28) | 1.00 (0.04) | 0.91 (0.28) | 1.00 (0.10) | 0.99959 |
S2 | HPV vaccination | Three doses of HPV vaccine (Emily) | 2 (2) | 79.8 (19.2) | 85.0 (23.5) | 0.92 (0.27) | 1.00 (0.01) | 0.91 (0.28) | 1.00 (0.01) | 0.99793 |
S3 | Screened; HPV positive, endoscopy normal | HPV positive and cytology negative; follow-up OPSCC screening in 12 months (Sam) | 3 (1) | 69.0 (18.2) | 70.0 (20.0) | 0.92 (0.28) | 1.00 (0.01) | 0.91 (0.28) | 1.00 (0.01) | 0.99309 |
S4 | Oral warts | Treatment for oral warts associated with HPV infection (Rachel) | 4 (1) | 68.0 (20.5) | 70.0 (26.5) | 0.88 (0.32) | 1.00 (0.00) | 0.88 (0.32) | 1.00 (0.00) | 0.99998 |
S5 | HG cytology with OIN II-III | High grade cytology with histologically-confirmed grade II/III oral intraepithelial neoplasia (Max) | 5 (0) | 48.6 (20.4) | 50.0 (20.0) | 0.87 (0.34) | 1.00 (0.14) | 0.87 (0.34) | 1.00 (0.11) | 0.99664 |
S6 | Early stage invasive throat cancer | Early stage invasive throat cancer requiring laryngectomy (Mary) | 6 (0) | 25.9 (21.5) | 20.0 (30.0) | 0.75 (0.43) | 1.00 (0.81) | 0.79 (0.40) | 1.00 (0.00) | 0.45521 |